|
Cobra Biomanufacturing offers contract research and manufacturing services to the biopharmaceutical industry. It develops genetic research supplies for use in preclinical research and early clinical trial stages. The company helps its global clients navigate through regulatory requirements while designing and manufacturing novel proteins, viruses, and other cellular products for use in drug development and manufacturing processes. Clients use Cobra Biomanufacturing's products and technologies to develop gene-based disease therapies and vaccine products.
|
| | | Contact Information | |
Address: |
Stephenson Bldg., The Science Park Keele, Staffordshire ST5 5SP, United Kingdom
| | Phone: | +44-1782-714-181 | | Fax: | +44-1782-714-168 |
|
| Financial
Highlights | | Fiscal Year End: | September | | Revenue (2008): | 12.70 M | | Revenue Growth (1 yr): | (-32.30%) |
|
|
Key People
| | |
Chairman:
Daniel (Danny) Chapchal
| | |
CEO:
Simon Saxby
| | |
Director, Finance and Company Secretary:
Peter Coleman
|
|
|